Scripps Research Institute
| |
Award Total: $15,525,577 |
# of Awards: 34 |
Home Page: |
Investigators
| |
William Balch , Ph.D. -
Carole Banka , Ph.D. -
William Boisvert , Ph.D. -
Adrie Bruijnzeel , Ph.D. -
Tsung-Hsien Chuang , Ph.D. -
Linda Curtiss , Ph.D. -
Linda Curtiss , Ph.D. -
Linda Curtiss , Ph.D. -
Linda Curtiss , Ph.D. -
Cindy Ehlers , Ph.D. -
Cindy Ehlers , Ph.D. -
Cindy Ehlers , Ph.D. -
Asa Gustafsson , Ph.D. -
Aaron Ilan , Ph.D. -
Kim Janda , Ph.D. -
Kim Janda , Ph.D. -
Kayoko Kimbara , Ph.D. -
George Koob , Ph.D. -
George Koob , Ph.D. -
Jiing-Dwan Lee , Ph.D. -
Athina Markou , Ph.D. -
Athina Markou , Ph.D. -
Athina Markou , Ph.D. -
Merrill Mitler , Ph.D. -
Satyajit Mitra , Ph.D. -
Bryan O'Neill , BA Chemistry -
Timothy O'Toole , Ph.D. -
Neil Paterson , B.Sc., MBCh.B. -
Ralph Reisfeld , Ph.D. -
Ralph Reisfeld , Ph.D. -
Dietmar Seiffert , M.D. -
Svetlana Semenova , Ph.D. -
Svetlana Semenova , Ph.D. -
Peter Tobias , Ph.D. -
Jason Yano , Ph.D. -
|
Grants
| |
Title |
Cycle [sort] |
Award |
| |
Activation of Bnip3 in tobacco-induced heart disease |
2005 (Cycle XIV) |
$134,074 |
| |
Investigator(s): Asa Gustafsson , Ph.D. |
14KT-0109 |
| |
Brain wave assessment of tobacco cessation readiness |
1997 (Cycle VI) |
$115,487 |
| |
Investigator(s): Aaron Ilan , Ph.D. |
6KT-0312 |
| |
Bupropion and nicotine dependence: behavior & neurochemisty |
2005 (Cycle XIV) |
$37,500 |
| |
Investigator(s): Neil Paterson , B.Sc., MBCh.B. |
14FT-0056 |
| |
Conformationally constrained nicotine vaccines |
2005 (Cycle XIV) |
$778,921 |
| |
Investigator(s): Kim Janda , Ph.D. |
14RT-0110 |
| |
Defining mutagenesis pathways in tobacco-related cancer |
2005 (Cycle XIV) |
$58,993 |
| |
Investigator(s): Bryan O'Neill , BA Chemistry |
14DT-0137 |
| |
Developing treatments that lower blood cholesterol levels |
1997 (Cycle VI) |
$746,536 |
| |
Investigator(s): Linda Curtiss , Ph.D. |
6RT-0034 |
| |
Development of nicotine withdrawal measures |
2005 (Cycle XIV) |
$91,173 |
| |
Investigator(s): Svetlana Semenova , Ph.D. |
14IT-0053 |
| |
Electrophysiological Effects of Perinatal Nicotine Exposure |
1995 (Cycle IV) |
$446,225 |
| |
Investigator(s): Cindy Ehlers , Ph.D. |
4RT-0285 |
| |
Focal adhesion kinase regulation of Cox-2 in lung cancer |
2003 (Cycle XII) |
$74,520 |
| |
Investigator(s): Satyajit Mitra , Ph.D. |
12FT-0122 |
| |
Hormone replacement therapy, smoking & lipoprotein oxidation |
1998 (Cycle VII) |
$385,808 |
| |
Investigator(s): Carole Banka , Ph.D. |
7RT-0101 |
| |
Immunopharmacotherapy as a treatment for nicotine addiction |
2002 (Cycle XI) |
$515,270 |
| |
Investigator(s): Kim Janda , Ph.D. |
11RT-0174 |
| |
Inflammation, innate immunity, TLRs, and atherosclerosis |
2002 (Cycle XI) |
$697,650 |
| |
Investigator(s): Peter Tobias , Ph.D. |
11RT-0073 |
| |
Integrin Cytoplasmic Domains and Ligand Affinity Modulation |
1994 (Cycle III) |
$522,649 |
| |
Investigator(s): Timothy O'Toole , Ph.D. |
3RT-0320 |
| |
Macrophage function in atherosclerosis |
2000 (Cycle IX) |
$709,200 |
| |
Investigator(s): Linda Curtiss , Ph.D. |
9RT-0161 |
| |
Membrane Signaling Pathways of RAS/RAB Proteins |
1995 (Cycle IV) |
$574,559 |
| |
Investigator(s): William Balch , Ph.D. |
4RT-0222 |
| |
Modulating TLR9 Activation for Lung Cancer Therapy |
2007 (Cycle XVI) |
$762,411 |
| |
Investigator(s): Tsung-Hsien Chuang , Ph.D. |
16RT-0103 |
| |
Neuroadaptations underlying nicotine dependence |
2002 (Cycle XI) |
$60,379 |
| |
Investigator(s): Adrie Bruijnzeel , Ph.D. |
11FT-0112 |
| |
Neurobehavioral consequences of adolescent nicotine exposure |
2000 (Cycle IX) |
$120,000 |
| |
Investigator(s): Cindy Ehlers , Ph.D. |
9RT-0210 |
| |
Neurobehavioral consequences of adolescent nicotine exposure |
2001 (Cycle X) |
$630,710 |
| |
Investigator(s): Cindy Ehlers , Ph.D. |
10RT-0334 |
| |
Neurobiological substrates of nicotine addiction |
2001 (Cycle X) |
$402,852 |
| |
Investigator(s): Athina Markou , Ph.D. |
10RT-0074 |
| |
Neurobiological substrates of nicotine addiction |
2003 (Cycle XII) |
$723,613 |
| |
Investigator(s): Athina Markou , Ph.D. |
12RT-0231 |
| |
Neurobiological substrates of nicotine addiction |
1998 (Cycle VII) |
$742,393 |
| |
Investigator(s): Athina Markou , Ph.D. |
7RT-0004 |
| |
Nicotine dependence & schizophrenia |
2001 (Cycle X) |
$75,600 |
| |
Investigator(s): Svetlana Semenova , Ph.D. |
10FT-0323 |
| |
Nicotine self-administration in an animal model |
2003 (Cycle XII) |
$660,156 |
| |
Investigator(s): George Koob , Ph.D. |
12RT-0099 |
| |
Nicotine Self-Administration in an Animal Model |
2008 (Cycle XVII) |
$720,434 |
| |
Investigator(s): George Koob , Ph.D. |
17RT-0095 |
| |
Novel DNA vaccines for the treatment of lung cancer |
2000 (Cycle IX) |
$1,063,300 |
| |
Investigator(s): Ralph Reisfeld , Ph.D. |
9RT-0017 |
| |
Novel DNA vaccines for the treatment of lung cancer |
2003 (Cycle XII) |
$783,900 |
| |
Investigator(s): Ralph Reisfeld , Ph.D. |
12RT-0002 |
| |
Regulation of integrin activation by calcineurin |
2002 (Cycle XI) |
$68,437 |
| |
Investigator(s): Kayoko Kimbara , Ph.D. |
11FT-0111 |
| |
Structure of CYP2A6: the principal nicotine oxidase |
2003 (Cycle XII) |
$75,060 |
| |
Investigator(s): Jason Yano , Ph.D. |
12FT-0185 |
| |
The effect of nicotine and cigarette smoke on respiration |
1998 (Cycle VII) |
$130,177 |
| |
Investigator(s): Merrill Mitler , Ph.D. |
7IT-0086 |
| |
Tobacco smoke, inflammation & atherosclerosis |
2001 (Cycle X) |
$754,932 |
| |
Investigator(s): Linda Curtiss , Ph.D. |
10RT-0089 |
| |
Tobacco use and atherosclerosis protection by paraoxonase |
2004 (Cycle XIII) |
$729,234 |
| |
Investigator(s): Linda Curtiss , Ph.D. |
13RT-0087 |
| |
Unraveling lung cancer signaling pathways |
2006 (Cycle XV) |
$780,780 |
| |
Investigator(s): Jiing-Dwan Lee , Ph.D. |
15RT-0104 |
| |
Vitronectin in Cardiovascular Disease |
1995 (Cycle IV) |
$352,644 |
| |
Investigator(s): Dietmar Seiffert , M.D. |
4KT-0192 |
|
